 | • レポートコード：MRC2-11QY03495 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は気管支肺異形成症治療薬のグローバル市場について調査・分析したレポートです。種類別（ブデソニド、クエン酸カフェイン、CG-100、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別気管支肺異形成症治療薬の競争状況、市場シェア ・世界の気管支肺異形成症治療薬市場：種類別市場規模 2015年-2020年（ブデソニド、クエン酸カフェイン、CG-100、その他） ・世界の気管支肺異形成症治療薬市場：種類別市場規模予測 2021年-2026年（ブデソニド、クエン酸カフェイン、CG-100、その他） ・世界の気管支肺異形成症治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の気管支肺異形成症治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の気管支肺異形成症治療薬市場分析：米国、カナダ ・ヨーロッパの気管支肺異形成症治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの気管支肺異形成症治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の気管支肺異形成症治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの気管支肺異形成症治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Chiesi Farmaceutici SpA、Insmed Inc、Martindale Pharmaceuticals Ltd、MediPost Co Ltd、Meridigen Biotech Co Ltd、Therabron Therapeutics Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Bronchopulmonary Dysplasia Drug Market
The global Bronchopulmonary Dysplasia Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Bronchopulmonary Dysplasia Drug Scope and Market Size
Bronchopulmonary Dysplasia Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bronchopulmonary Dysplasia Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Bronchopulmonary Dysplasia Drug market is segmented into
Budesonide
Caffeine Citrate
CG-100
Others
Segment by Application, the Bronchopulmonary Dysplasia Drug market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Bronchopulmonary Dysplasia Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Bronchopulmonary Dysplasia Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Bronchopulmonary Dysplasia Drug Market Share Analysis
Bronchopulmonary Dysplasia Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Bronchopulmonary Dysplasia Drug business, the date to enter into the Bronchopulmonary Dysplasia Drug market, Bronchopulmonary Dysplasia Drug product introduction, recent developments, etc.
The major vendors covered:
Chiesi Farmaceutici SpA
Insmed Inc
Martindale Pharmaceuticals Ltd
MediPost Co Ltd
Meridigen Biotech Co Ltd
Therabron Therapeutics Inc
…
1 Study Coverage
1.1 Bronchopulmonary Dysplasia Drug Product Introduction
1.2 Market Segments
1.3 Key Bronchopulmonary Dysplasia Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Bronchopulmonary Dysplasia Drug Market Size Growth Rate by Type
1.4.2 Budesonide
1.4.3 Caffeine Citrate
1.4.4 CG-100
1.4.5 Others
1.5 Market by Application
1.5.1 Global Bronchopulmonary Dysplasia Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Bronchopulmonary Dysplasia Drug Market Size, Estimates and Forecasts
2.1.1 Global Bronchopulmonary Dysplasia Drug Revenue 2015-2026
2.1.2 Global Bronchopulmonary Dysplasia Drug Sales 2015-2026
2.2 Global Bronchopulmonary Dysplasia Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Bronchopulmonary Dysplasia Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Bronchopulmonary Dysplasia Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Bronchopulmonary Dysplasia Drug Competitor Landscape by Players
3.1 Bronchopulmonary Dysplasia Drug Sales by Manufacturers
3.1.1 Bronchopulmonary Dysplasia Drug Sales by Manufacturers (2015-2020)
3.1.2 Bronchopulmonary Dysplasia Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Bronchopulmonary Dysplasia Drug Revenue by Manufacturers
3.2.1 Bronchopulmonary Dysplasia Drug Revenue by Manufacturers (2015-2020)
3.2.2 Bronchopulmonary Dysplasia Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Bronchopulmonary Dysplasia Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Bronchopulmonary Dysplasia Drug Revenue in 2019
3.2.5 Global Bronchopulmonary Dysplasia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Bronchopulmonary Dysplasia Drug Price by Manufacturers
3.4 Bronchopulmonary Dysplasia Drug Manufacturing Base Distribution, Product Types
3.4.1 Bronchopulmonary Dysplasia Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bronchopulmonary Dysplasia Drug Product Type
3.4.3 Date of International Manufacturers Enter into Bronchopulmonary Dysplasia Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bronchopulmonary Dysplasia Drug Market Size by Type (2015-2020)
4.1.1 Global Bronchopulmonary Dysplasia Drug Sales by Type (2015-2020)
4.1.2 Global Bronchopulmonary Dysplasia Drug Revenue by Type (2015-2020)
4.1.3 Bronchopulmonary Dysplasia Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Bronchopulmonary Dysplasia Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Bronchopulmonary Dysplasia Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Bronchopulmonary Dysplasia Drug Revenue Forecast by Type (2021-2026)
4.2.3 Bronchopulmonary Dysplasia Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Bronchopulmonary Dysplasia Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Bronchopulmonary Dysplasia Drug Market Size by Application (2015-2020)
5.1.1 Global Bronchopulmonary Dysplasia Drug Sales by Application (2015-2020)
5.1.2 Global Bronchopulmonary Dysplasia Drug Revenue by Application (2015-2020)
5.1.3 Bronchopulmonary Dysplasia Drug Price by Application (2015-2020)
5.2 Bronchopulmonary Dysplasia Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Bronchopulmonary Dysplasia Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Bronchopulmonary Dysplasia Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Bronchopulmonary Dysplasia Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Bronchopulmonary Dysplasia Drug by Country
6.1.1 North America Bronchopulmonary Dysplasia Drug Sales by Country
6.1.2 North America Bronchopulmonary Dysplasia Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Bronchopulmonary Dysplasia Drug Market Facts & Figures by Type
6.3 North America Bronchopulmonary Dysplasia Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Bronchopulmonary Dysplasia Drug by Country
7.1.1 Europe Bronchopulmonary Dysplasia Drug Sales by Country
7.1.2 Europe Bronchopulmonary Dysplasia Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Bronchopulmonary Dysplasia Drug Market Facts & Figures by Type
7.3 Europe Bronchopulmonary Dysplasia Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Bronchopulmonary Dysplasia Drug by Region
8.1.1 Asia Pacific Bronchopulmonary Dysplasia Drug Sales by Region
8.1.2 Asia Pacific Bronchopulmonary Dysplasia Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Bronchopulmonary Dysplasia Drug Market Facts & Figures by Type
8.3 Asia Pacific Bronchopulmonary Dysplasia Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Bronchopulmonary Dysplasia Drug by Country
9.1.1 Latin America Bronchopulmonary Dysplasia Drug Sales by Country
9.1.2 Latin America Bronchopulmonary Dysplasia Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Bronchopulmonary Dysplasia Drug Market Facts & Figures by Type
9.3 Central & South America Bronchopulmonary Dysplasia Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Bronchopulmonary Dysplasia Drug by Country
10.1.1 Middle East and Africa Bronchopulmonary Dysplasia Drug Sales by Country
10.1.2 Middle East and Africa Bronchopulmonary Dysplasia Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Bronchopulmonary Dysplasia Drug Market Facts & Figures by Type
10.3 Middle East and Africa Bronchopulmonary Dysplasia Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Chiesi Farmaceutici SpA
11.1.1 Chiesi Farmaceutici SpA Corporation Information
11.1.2 Chiesi Farmaceutici SpA Description and Business Overview
11.1.3 Chiesi Farmaceutici SpA Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Chiesi Farmaceutici SpA Bronchopulmonary Dysplasia Drug Products Offered
11.1.5 Chiesi Farmaceutici SpA Related Developments
11.2 Insmed Inc
11.2.1 Insmed Inc Corporation Information
11.2.2 Insmed Inc Description and Business Overview
11.2.3 Insmed Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Insmed Inc Bronchopulmonary Dysplasia Drug Products Offered
11.2.5 Insmed Inc Related Developments
11.3 Martindale Pharmaceuticals Ltd
11.3.1 Martindale Pharmaceuticals Ltd Corporation Information
11.3.2 Martindale Pharmaceuticals Ltd Description and Business Overview
11.3.3 Martindale Pharmaceuticals Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Martindale Pharmaceuticals Ltd Bronchopulmonary Dysplasia Drug Products Offered
11.3.5 Martindale Pharmaceuticals Ltd Related Developments
11.4 MediPost Co Ltd
11.4.1 MediPost Co Ltd Corporation Information
11.4.2 MediPost Co Ltd Description and Business Overview
11.4.3 MediPost Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.4.4 MediPost Co Ltd Bronchopulmonary Dysplasia Drug Products Offered
11.4.5 MediPost Co Ltd Related Developments
11.5 Meridigen Biotech Co Ltd
11.5.1 Meridigen Biotech Co Ltd Corporation Information
11.5.2 Meridigen Biotech Co Ltd Description and Business Overview
11.5.3 Meridigen Biotech Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Meridigen Biotech Co Ltd Bronchopulmonary Dysplasia Drug Products Offered
11.5.5 Meridigen Biotech Co Ltd Related Developments
11.6 Therabron Therapeutics Inc
11.6.1 Therabron Therapeutics Inc Corporation Information
11.6.2 Therabron Therapeutics Inc Description and Business Overview
11.6.3 Therabron Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Therabron Therapeutics Inc Bronchopulmonary Dysplasia Drug Products Offered
11.6.5 Therabron Therapeutics Inc Related Developments
11.1 Chiesi Farmaceutici SpA
11.1.1 Chiesi Farmaceutici SpA Corporation Information
11.1.2 Chiesi Farmaceutici SpA Description and Business Overview
11.1.3 Chiesi Farmaceutici SpA Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Chiesi Farmaceutici SpA Bronchopulmonary Dysplasia Drug Products Offered
11.1.5 Chiesi Farmaceutici SpA Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Bronchopulmonary Dysplasia Drug Market Estimates and Projections by Region
12.1.1 Global Bronchopulmonary Dysplasia Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Bronchopulmonary Dysplasia Drug Revenue Forecast by Regions 2021-2026
12.2 North America Bronchopulmonary Dysplasia Drug Market Size Forecast (2021-2026)
12.2.1 North America: Bronchopulmonary Dysplasia Drug Sales Forecast (2021-2026)
12.2.2 North America: Bronchopulmonary Dysplasia Drug Revenue Forecast (2021-2026)
12.2.3 North America: Bronchopulmonary Dysplasia Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Bronchopulmonary Dysplasia Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Bronchopulmonary Dysplasia Drug Sales Forecast (2021-2026)
12.3.2 Europe: Bronchopulmonary Dysplasia Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Bronchopulmonary Dysplasia Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Bronchopulmonary Dysplasia Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Bronchopulmonary Dysplasia Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Bronchopulmonary Dysplasia Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Bronchopulmonary Dysplasia Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Bronchopulmonary Dysplasia Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Bronchopulmonary Dysplasia Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Bronchopulmonary Dysplasia Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Bronchopulmonary Dysplasia Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Bronchopulmonary Dysplasia Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Bronchopulmonary Dysplasia Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Bronchopulmonary Dysplasia Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Bronchopulmonary Dysplasia Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Bronchopulmonary Dysplasia Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Bronchopulmonary Dysplasia Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Bronchopulmonary Dysplasia Drug Market Segments
Table 2. Ranking of Global Top Bronchopulmonary Dysplasia Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Bronchopulmonary Dysplasia Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Budesonide
Table 5. Major Manufacturers of Caffeine Citrate
Table 6. Major Manufacturers of CG-100
Table 7. Major Manufacturers of Others
Table 8. Global Bronchopulmonary Dysplasia Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Bronchopulmonary Dysplasia Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Bronchopulmonary Dysplasia Drug Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Bronchopulmonary Dysplasia Drug Sales Market Share by Regions (2015-2020)
Table 12. Global Bronchopulmonary Dysplasia Drug Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Bronchopulmonary Dysplasia Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Bronchopulmonary Dysplasia Drug Sales Share by Manufacturers (2015-2020)
Table 15. Global Bronchopulmonary Dysplasia Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Bronchopulmonary Dysplasia Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bronchopulmonary Dysplasia Drug as of 2019)
Table 17. Bronchopulmonary Dysplasia Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Bronchopulmonary Dysplasia Drug Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Bronchopulmonary Dysplasia Drug Price (2015-2020) (USD/Pcs)
Table 20. Bronchopulmonary Dysplasia Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Bronchopulmonary Dysplasia Drug Product Type
Table 22. Date of International Manufacturers Enter into Bronchopulmonary Dysplasia Drug Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Bronchopulmonary Dysplasia Drug Sales by Type (2015-2020) (K Pcs)
Table 25. Global Bronchopulmonary Dysplasia Drug Sales Share by Type (2015-2020)
Table 26. Global Bronchopulmonary Dysplasia Drug Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Bronchopulmonary Dysplasia Drug Revenue Share by Type (2015-2020)
Table 28. Bronchopulmonary Dysplasia Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Bronchopulmonary Dysplasia Drug Sales by Application (2015-2020) (K Pcs)
Table 30. Global Bronchopulmonary Dysplasia Drug Sales Share by Application (2015-2020)
Table 31. North America Bronchopulmonary Dysplasia Drug Sales by Country (2015-2020) (K Pcs)
Table 32. North America Bronchopulmonary Dysplasia Drug Sales Market Share by Country (2015-2020)
Table 33. North America Bronchopulmonary Dysplasia Drug Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Bronchopulmonary Dysplasia Drug Revenue Market Share by Country (2015-2020)
Table 35. North America Bronchopulmonary Dysplasia Drug Sales by Type (2015-2020) (K Pcs)
Table 36. North America Bronchopulmonary Dysplasia Drug Sales Market Share by Type (2015-2020)
Table 37. North America Bronchopulmonary Dysplasia Drug Sales by Application (2015-2020) (K Pcs)
Table 38. North America Bronchopulmonary Dysplasia Drug Sales Market Share by Application (2015-2020)
Table 39. Europe Bronchopulmonary Dysplasia Drug Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Bronchopulmonary Dysplasia Drug Sales Market Share by Country (2015-2020)
Table 41. Europe Bronchopulmonary Dysplasia Drug Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Bronchopulmonary Dysplasia Drug Revenue Market Share by Country (2015-2020)
Table 43. Europe Bronchopulmonary Dysplasia Drug Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Bronchopulmonary Dysplasia Drug Sales Market Share by Type (2015-2020)
Table 45. Europe Bronchopulmonary Dysplasia Drug Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Bronchopulmonary Dysplasia Drug Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Bronchopulmonary Dysplasia Drug Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Bronchopulmonary Dysplasia Drug Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Bronchopulmonary Dysplasia Drug Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Bronchopulmonary Dysplasia Drug Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Bronchopulmonary Dysplasia Drug Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Bronchopulmonary Dysplasia Drug Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Bronchopulmonary Dysplasia Drug Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Bronchopulmonary Dysplasia Drug Sales Market Share by Application (2015-2020)
Table 55. Latin America Bronchopulmonary Dysplasia Drug Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Bronchopulmonary Dysplasia Drug Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Bronchopulmonary Dysplasia Drug Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Bronchopulmonary Dysplasia Drug Revenue Market Share by Country (2015-2020)
Table 59. Latin America Bronchopulmonary Dysplasia Drug Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Bronchopulmonary Dysplasia Drug Sales Market Share by Type (2015-2020)
Table 61. Latin America Bronchopulmonary Dysplasia Drug Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Bronchopulmonary Dysplasia Drug Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Bronchopulmonary Dysplasia Drug Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Bronchopulmonary Dysplasia Drug Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Bronchopulmonary Dysplasia Drug Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Bronchopulmonary Dysplasia Drug Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Bronchopulmonary Dysplasia Drug Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Bronchopulmonary Dysplasia Drug Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Bronchopulmonary Dysplasia Drug Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Bronchopulmonary Dysplasia Drug Sales Market Share by Application (2015-2020)
Table 71. Chiesi Farmaceutici SpA Corporation Information
Table 72. Chiesi Farmaceutici SpA Description and Major Businesses
Table 73. Chiesi Farmaceutici SpA Bronchopulmonary Dysplasia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Chiesi Farmaceutici SpA Product
Table 75. Chiesi Farmaceutici SpA Recent Development
Table 76. Insmed Inc Corporation Information
Table 77. Insmed Inc Description and Major Businesses
Table 78. Insmed Inc Bronchopulmonary Dysplasia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Insmed Inc Product
Table 80. Insmed Inc Recent Development
Table 81. Martindale Pharmaceuticals Ltd Corporation Information
Table 82. Martindale Pharmaceuticals Ltd Description and Major Businesses
Table 83. Martindale Pharmaceuticals Ltd Bronchopulmonary Dysplasia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Martindale Pharmaceuticals Ltd Product
Table 85. Martindale Pharmaceuticals Ltd Recent Development
Table 86. MediPost Co Ltd Corporation Information
Table 87. MediPost Co Ltd Description and Major Businesses
Table 88. MediPost Co Ltd Bronchopulmonary Dysplasia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. MediPost Co Ltd Product
Table 90. MediPost Co Ltd Recent Development
Table 91. Meridigen Biotech Co Ltd Corporation Information
Table 92. Meridigen Biotech Co Ltd Description and Major Businesses
Table 93. Meridigen Biotech Co Ltd Bronchopulmonary Dysplasia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Meridigen Biotech Co Ltd Product
Table 95. Meridigen Biotech Co Ltd Recent Development
Table 96. Therabron Therapeutics Inc Corporation Information
Table 97. Therabron Therapeutics Inc Description and Major Businesses
Table 98. Therabron Therapeutics Inc Bronchopulmonary Dysplasia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. Therabron Therapeutics Inc Product
Table 100. Therabron Therapeutics Inc Recent Development
Table 101. Global Bronchopulmonary Dysplasia Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 102. Global Bronchopulmonary Dysplasia Drug Sales Market Share Forecast by Regions (2021-2026)
Table 103. Global Bronchopulmonary Dysplasia Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 104. Global Bronchopulmonary Dysplasia Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 105. North America: Bronchopulmonary Dysplasia Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 106. North America: Bronchopulmonary Dysplasia Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Europe: Bronchopulmonary Dysplasia Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 108. Europe: Bronchopulmonary Dysplasia Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Asia Pacific: Bronchopulmonary Dysplasia Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 110. Asia Pacific: Bronchopulmonary Dysplasia Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 111. Latin America: Bronchopulmonary Dysplasia Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 112. Latin America: Bronchopulmonary Dysplasia Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Middle East and Africa: Bronchopulmonary Dysplasia Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 114. Middle East and Africa: Bronchopulmonary Dysplasia Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 116. Key Challenges
Table 117. Market Risks
Table 118. Main Points Interviewed from Key Bronchopulmonary Dysplasia Drug Players
Table 119. Bronchopulmonary Dysplasia Drug Customers List
Table 120. Bronchopulmonary Dysplasia Drug Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Bronchopulmonary Dysplasia Drug Product Picture
Figure 2. Global Bronchopulmonary Dysplasia Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Budesonide Product Picture
Figure 4. Caffeine Citrate Product Picture
Figure 5. CG-100 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Bronchopulmonary Dysplasia Drug Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Bronchopulmonary Dysplasia Drug Report Years Considered
Figure 12. Global Bronchopulmonary Dysplasia Drug Market Size 2015-2026 (US$ Million)
Figure 13. Global Bronchopulmonary Dysplasia Drug Sales 2015-2026 (K Pcs)
Figure 14. Global Bronchopulmonary Dysplasia Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Bronchopulmonary Dysplasia Drug Sales Market Share by Region (2015-2020)
Figure 16. Global Bronchopulmonary Dysplasia Drug Sales Market Share by Region in 2019
Figure 17. Global Bronchopulmonary Dysplasia Drug Revenue Market Share by Region (2015-2020)
Figure 18. Global Bronchopulmonary Dysplasia Drug Revenue Market Share by Region in 2019
Figure 19. Global Bronchopulmonary Dysplasia Drug Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Bronchopulmonary Dysplasia Drug Revenue in 2019
Figure 21. Bronchopulmonary Dysplasia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Bronchopulmonary Dysplasia Drug Sales Market Share by Type (2015-2020)
Figure 23. Global Bronchopulmonary Dysplasia Drug Sales Market Share by Type in 2019
Figure 24. Global Bronchopulmonary Dysplasia Drug Revenue Market Share by Type (2015-2020)
Figure 25. Global Bronchopulmonary Dysplasia Drug Revenue Market Share by Type in 2019
Figure 26. Global Bronchopulmonary Dysplasia Drug Market Share by Price Range (2015-2020)
Figure 27. Global Bronchopulmonary Dysplasia Drug Sales Market Share by Application (2015-2020)
Figure 28. Global Bronchopulmonary Dysplasia Drug Sales Market Share by Application in 2019
Figure 29. Global Bronchopulmonary Dysplasia Drug Revenue Market Share by Application (2015-2020)
Figure 30. Global Bronchopulmonary Dysplasia Drug Revenue Market Share by Application in 2019
Figure 31. North America Bronchopulmonary Dysplasia Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America Bronchopulmonary Dysplasia Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Bronchopulmonary Dysplasia Drug Sales Market Share by Country in 2019
Figure 34. North America Bronchopulmonary Dysplasia Drug Revenue Market Share by Country in 2019
Figure 35. U.S. Bronchopulmonary Dysplasia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. Bronchopulmonary Dysplasia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Bronchopulmonary Dysplasia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada Bronchopulmonary Dysplasia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Bronchopulmonary Dysplasia Drug Market Share by Type in 2019
Figure 40. North America Bronchopulmonary Dysplasia Drug Market Share by Application in 2019
Figure 41. Europe Bronchopulmonary Dysplasia Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe Bronchopulmonary Dysplasia Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Bronchopulmonary Dysplasia Drug Sales Market Share by Country in 2019
Figure 44. Europe Bronchopulmonary Dysplasia Drug Revenue Market Share by Country in 2019
Figure 45. Germany Bronchopulmonary Dysplasia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany Bronchopulmonary Dysplasia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Bronchopulmonary Dysplasia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France Bronchopulmonary Dysplasia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Bronchopulmonary Dysplasia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. Bronchopulmonary Dysplasia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Bronchopulmonary Dysplasia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy Bronchopulmonary Dysplasia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Bronchopulmonary Dysplasia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia Bronchopulmonary Dysplasia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Bronchopulmonary Dysplasia Drug Market Share by Type in 2019
Figure 56. Europe Bronchopulmonary Dysplasia Drug Market Share by Application in 2019
Figure 57. Asia Pacific Bronchopulmonary Dysplasia Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific Bronchopulmonary Dysplasia Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Bronchopulmonary Dysplasia Drug Sales Market Share by Region in 2019
Figure 60. Asia Pacific Bronchopulmonary Dysplasia Drug Revenue Market Share by Region in 2019
Figure 61. China Bronchopulmonary Dysplasia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China Bronchopulmonary Dysplasia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Bronchopulmonary Dysplasia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Bronchopulmonary Dysplasia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Bronchopulmonary Dysplasia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea Bronchopulmonary Dysplasia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Bronchopulmonary Dysplasia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India Bronchopulmonary Dysplasia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Bronchopulmonary Dysplasia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia Bronchopulmonary Dysplasia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Bronchopulmonary Dysplasia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan Bronchopulmonary Dysplasia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Bronchopulmonary Dysplasia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia Bronchopulmonary Dysplasia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Bronchopulmonary Dysplasia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand Bronchopulmonary Dysplasia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Bronchopulmonary Dysplasia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia Bronchopulmonary Dysplasia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Bronchopulmonary Dysplasia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines Bronchopulmonary Dysplasia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Bronchopulmonary Dysplasia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam Bronchopulmonary Dysplasia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Bronchopulmonary Dysplasia Drug Market Share by Type in 2019
Figure 84. Asia Pacific Bronchopulmonary Dysplasia Drug Market Share by Application in 2019
Figure 85. Latin America Bronchopulmonary Dysplasia Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Bronchopulmonary Dysplasia Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Bronchopulmonary Dysplasia Drug Sales Market Share by Country in 2019
Figure 88. Latin America Bronchopulmonary Dysplasia Drug Revenue Market Share by Country in 2019
Figure 89. Mexico Bronchopulmonary Dysplasia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Bronchopulmonary Dysplasia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Bronchopulmonary Dysplasia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Bronchopulmonary Dysplasia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Bronchopulmonary Dysplasia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Bronchopulmonary Dysplasia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Bronchopulmonary Dysplasia Drug Market Share by Type in 2019
Figure 96. Latin America Bronchopulmonary Dysplasia Drug Market Share by Application in 2019
Figure 97. Middle East and Africa Bronchopulmonary Dysplasia Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Bronchopulmonary Dysplasia Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Bronchopulmonary Dysplasia Drug Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Bronchopulmonary Dysplasia Drug Revenue Market Share by Country in 2019
Figure 101. Turkey Bronchopulmonary Dysplasia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Bronchopulmonary Dysplasia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Bronchopulmonary Dysplasia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Bronchopulmonary Dysplasia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Bronchopulmonary Dysplasia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E Bronchopulmonary Dysplasia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Bronchopulmonary Dysplasia Drug Market Share by Type in 2019
Figure 108. Middle East and Africa Bronchopulmonary Dysplasia Drug Market Share by Application in 2019
Figure 109. North America Bronchopulmonary Dysplasia Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. North America Bronchopulmonary Dysplasia Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Bronchopulmonary Dysplasia Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Europe Bronchopulmonary Dysplasia Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Bronchopulmonary Dysplasia Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Asia Pacific Bronchopulmonary Dysplasia Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Bronchopulmonary Dysplasia Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Latin America Bronchopulmonary Dysplasia Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Bronchopulmonary Dysplasia Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Middle East and Africa Bronchopulmonary Dysplasia Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
気管支肺異形成症の世界市場（～2026年） Bronchopulmonary dysplasia, a type of chronic lung disorder, affects newborns, mostly premature and infants. Lungs and bronchi are damaged at the neonatal phase which causes destruction of tiny air sacs known as alveoli. Babies are not born with the disease. The condition is developed when premature…- 子宮頸部異形成の世界市場（～2026年） Cervical dysplasia is a precancerous condition in which abnormal cell growth occurs on the surface lining of the cervix or endocervical canal, the opening between the uterus and the vagina. It is also called cervical intraepithelial neoplasia (CIN). Market Analysis and Insights: Global Cervical Dysp…
- 子宮頸部異形成治療の世界市場（～2026年） A precancerous condition where abnormal cell growth occurs at the opening of the cervix is known as cervical dysplasia. Alternatively, it is known as cervical intraepithelial neoplasia. This disease affects the women of all ages but occurs commonly in the age group of 25 to 35 years old. The cervica…
- 小売薬の世界市場（～2026年） A drug is any substance (other than food that provides nutritional support) that, when inhaled, injected, smoked, consumed, absorbed via a patch on the skin, or dissolved under the tongue causes a temporary physiological (and often psychological) change in the body. Increasing industry share of Asia…
- 大麻薬の世界市場（～2026年） Drugs with chemicals taken directly from the marijuana plant，or with synthetic versions of chemicals naturally found in marijuana. Market Analysis and Insights: Global Cannabis Drug Market The global Cannabis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020,…